Table 2.
Proportion of Salmonella serotypes resistant to therapeutic antibiotics during a 12-year intervals.
| Proportion of resistant isolates (%) (95% CIs) |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Year | Strain (n) | AMP | CHL | TMP-SMX | CIP | NAL | CAZ | CRO | CTX | ZOX | CFM |
| 1983-1995 | 597 | 86.1 (83–88.6) |
80.5 (69.7–88.1) |
73.2 (69.3–76.7) |
0.4 (0–5.2) |
2.9 (1.8–4.7) |
NA | NA | NA | NA | NA |
| 1995-2008 | 1052 | 28.3 (12.8–51.7) |
17.2 (10.5–26.8) |
29.7 (22.3–38.2) |
2.2 (0.9–5.4) |
49.8 (39.3–60.4) |
5.1 (1.5–16.1) |
10.3 (1.2–52.6) |
6.5 (0.7–40.3) |
70.7 (18–96.4) |
0 |
| 2008-2019 | 2341 | 32.5 (21–46.5) |
28 (18.5–40) |
35.4 (25.1–47.2) |
3.5 (1.1–11) |
56.7 (48.6–64.4) |
7.7 (4.6–12.5) |
9.1 (5.3–15.2) |
8.2 (4.5–14.5) |
17.9 (1.5–76) |
5.8 (3.4–9.6) |
Abbreviations: AMP-ampicillin; CHL-chloramphenicol; TMP/SMX-trimethoprim-sulfamethoxazole; CIP-ciprofloxacin; NAL-nalidixic acid; CAZ-ceftazidime; CRO-ceftriaxone; CTX-cefotaxime; ZOX-ceftizoxime; CFM-cefixime; NA-data not available.